A LinkedIn post from vopemed indicates the company plans to participate in the SAGES NBT 2026 Innovation Weekend and Surgical Disruptive Technology Summit in Houston. The post notes that the event convenes surgeons and technology developers focused on minimally invasive surgery, including AI, robotics, mixed reality, simulation, and data-driven performance tools.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, vopemed’s CEO and founder, Amy Lorincz, is scheduled to speak on a panel titled “My Favorite Digital Tool to Improve My Performance” on February 20, 2026. This visibility alongside surgeons, engineers, and digital health leaders may enhance vopemed’s positioning within the surgical AI and medtech ecosystem and could support future partnership, adoption, and commercialization opportunities.
The post also highlights interest in how digital technologies can improve surgeon performance in the operating room, suggesting vopemed is aligning its product narrative with measurable clinical and workflow outcomes. For investors, participation in a specialist forum with institutions such as Mayo Clinic, Houston Methodist, Cedars-Sinai, and major surgical-technology players could be a signal of ongoing business development efforts and potential access to key opinion leaders and early adopters.